• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:张林琪,苏文俏,郭建军*,游宇,胡林,周文.UPLC-MS/MS测定人血浆中长春西汀和阿朴长春胺酸的含量及其应用[J].中国现代应用药学,2023,40(4):489-493.
ZHANG Linqi,SU Wenqiao,GUO Jianjun*,YOU Yu,HU Lin,ZHOU Wen.Determination of vinpocetine and Apovincaminic acid in Human plasma by UPLC-MS/MS and its Application[J].Chin J Mod Appl Pharm(中国现代应用药学),2023,40(4):489-493.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1136次   下载 648 本文二维码信息
码上扫一扫!
分享到: 微信 更多
UPLC-MS/MS测定人血浆中长春西汀和阿朴长春胺酸的含量及其应用
张林琪, 苏文俏, 郭建军*, 游宇, 胡林, 周文
湖南恒兴医药科技有限公司, 长沙 410205
摘要:
目的 建立和验证UPLC-MS/MS测定人血浆中长春西汀和阿朴长春胺酸的方法,并用于临床样品检测。方法 以长春西汀-d5、阿朴长春胺酸-d4为内标,人血浆样品经蛋白沉淀法沉淀处理,色谱柱为Waters ACQUITY UPLC® BEH C18(2.1 mm×50 mm,1.7 μm),流动相为乙腈-水(含0.05%甲酸),梯度洗脱,流速0.35 mL·min-1;电喷雾离子化源正离子监测模式。结果 长春西汀和阿朴长春胺酸线性范围分别为0.04~20.0 ng·mL-1(r=0.999 7)、0.50~250 ng·mL-1(r=0.999 6),检测限分别为0.01,0.10 ng·mL-1,待测物与内标提取回收率均为94.81%~105.0%,基质效应为94.51%~105.0%,RSD均< 5%;批内、批间精密度RSD均<10%。结论 本法特异性强、快速、准确,重复性好,适用于长春西汀临床生物样品检测及生物等效性研究。
关键词:  长春西汀  阿朴长春胺酸  血药浓度  超高效液相色谱串联质谱法
DOI:10.13748/j.cnki.issn1007-7693.2023.04.009
分类号:R917
基金项目:
Determination of vinpocetine and Apovincaminic acid in Human plasma by UPLC-MS/MS and its Application
ZHANG Linqi, SU Wenqiao, GUO Jianjun*, YOU Yu, HU Lin, ZHOU Wen
EverPro Medical Co., Ltd., Changsha 410205, China
Abstract:
OBJECTIVE To establish and validate a UPLC-MS/MS for the determination of vinpocetine and apovincaminic acid in human plasma and apply to the determination of clinical samples. METHODS Vinpocetine-d5 and apovincaminic acid-d4 were used as internal standards. Human plasma samples were prepared with acetonitrile to precipitate to protein. The chromatographic column was Waters ACQUITY UPLC® BEH C18(2.1 mm×50 mm, 1.7 μm), the mobile phase was acetonitrile-water(containing 0.05% formic acid). Gradient elution with a flow rate of 0.35 mL·min-1. Mass spectrometry conditions: Electrospray ionization source(ESI), positive ion detection mode. RESULTS The linear range were 0.04-20.0 ng·mL-1(r=0.999 7) for vinpocetine and 0.50-250 ng·mL-1(r=0.999 6) for apovincaminic acid, and the limit of quantification were 0.01, 0.10 ng·mL-1, respectively. The recoveries of test sample and internal standard were in the range of 94.81%-105.0%, and the matrix effect were 94.51%-105.0%, RSDs were <5%. The RSDs of intra- and inter-batch precision were all <10%. CONCLUSION The method is specific, rapid, accurate and reproducible. Therefore, it is suitable for the determination of vinpocetine concentration in plasma and can applied to its bioequivalence study.
Key words:  vinpocetine  apovincaminic acid  plasma concentration  UPLC-MS/MS
扫一扫关注本刊微信